TITLE

Pretransplantation Respiratory Syncytial Virus Infection: Impact of a Strategy to Delay Transplantation

AUTHOR(S)
Peck, Angela J.; Corey, Lawrence; Boeckh, Michael
PUB. DATE
September 2004
SOURCE
Clinical Infectious Diseases;9/1/2004, Vol. 39 Issue 5, p673
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Delay of hematopoietic stem cell transplantation (HSCT) has been suggested if upper respiratory tract infection (URTI) due to respiratory syncytial virus (RSV) occurs in transplantation candidates, but the efficacy of this strategy in preventing posttransplantation RSV infection is unknown. Methods. in a retrospective study, we reviewed charts of patients who underwent transplantation at Fred Hutchinson Cancer Research Center (Seattle, WA) during the period of June 1987 through December 2000 and evaluated the strategy of delaying HSCT in candidates with laboratory-confirmed RSV URTI. Results. Thirty-one of 37 patients had RSV URTI before conditioning, 2 (6.5%) of whom developed RSV infection after HSCT. in 6 of 37 patients, symptoms of URTI were present during the start of conditioning, but RSV virologic confirmation occurred a median of 4.5 days (range, 2-5 days) into the conditioning regimen. Conditioning was aborted for 3 of 6 patients; none had progression to RSV pneumonia. Of the 3 patients in whom HSCT proceeded as scheduled, 2 developed RSV pneumonia. Overall, RSV pneumonia occurred in 1 of 34 patients for whom HSCT was delayed, compared with 2 of 3 patients for whom there was no delay (P = .01). Conclusions, in patients with pretransplantation RSV URT1, delay of HSCT was associated with a lower risk of pneumonia than was no delay. Because URT is can progress to severe complications in patients receiving HSCTs, these results support Centers for Disease Control and Prevention/American Society of Blood and Marrow Transplantation recommendations that HSCT be delayed on the basis of symptoms of URTI rather than waiting for virologic confirmation.
ACCESSION #
14174170

 

Related Articles

  • Palivizumab Treatment of Respiratory Syncytial Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation. de Fontbrune, Flore Sicre; Robin, Marie; Porcher, Raphael; Scieux, Catherine; de Latour, Régis Peffault; Ferry, Christèle; Rocha, Vanderson; Boudjedir, Karim; Devergie, Agnès; Bergeron, Anne; Gluckman, Eliane; Azoulay, Elie; Lapalu, Jordane; Socié, Gérard; Ribaud, Patricia // Clinical Infectious Diseases;10/15/2007, Vol. 45 Issue 8, p1019 

    Among 40 allogeneic stem cell transplant recipients who developed symptomatic respiratory syncytial virus infection, including 22 patients with lower respiratory tract infection, 19 received palivizumab (9 of whom had upper respiratory tract disease). Palivizumab did not prevent progression to...

  • The Synthetic Bacterial Lipopeptide Pam3CSK4 Modulates Respiratory Syncytial Virus Infection Independent of TLR Activation.  // PLoS Pathogens;Aug2010, Vol. 6 Issue 8, p1 

    No abstract available.

  • Hematologic Complication of Respiratory Virus Infection. In Ho Park; Su Ho Lee; Sung Taek You; Du Young Choi // Korean Journal of Pediatric Infectious Diseases;2013, Vol. 20 Issue 3, p178 

    Objective: Cytopenia is a common hematologic complication of viral infections. However, information regarding hematologic effects of common respiratory virus infections is scarce. This study aimed to evaluate hematologic complications and the clinical course of patients infected with common...

  • The Association of Newly Identified Respiratory Viruses with Lower Respiratory Tract Infections in Korean Children, 2000-2005. Eun Hwa Choi; Hoan Jong Lee; Sun Jung Kim; Byung Wook Eun; Nam Hee Kim; Lee, Jin A.; Jun Ho Lee; Eun Kyung Song; So Hee Kim; Ji Yong Park; Ji Yeon Sung // Clinical Infectious Diseases;9/1/2006, Vol. 43 Issue 5, p585 

    Background. This study was performed to evaluate the associations of newly recognized viruses, namely, human metapneumovirus (hMPV), human coronavirus (HCoV)-NL63, and human bocavirus (HBoV) with lower respiratory tract infections (LRTIs) in previously healthy children. Methods. To determine the...

  • Deaths from influenza and respiratory syncytial virus.  // Archives of Disease in Childhood;Oct2005, Vol. 90 Issue 10, p1070 

    The article presents information on influenza and respiratory syncytial virus (RSV) infections. RSV infections occur at about the same time each winter and may give rise to similar symptoms. The role of each virus in winter mortality is therefore unclear. National mortality data were analysed...

  • Human Metapneumovirus: A New Player among Respiratory Viruses. Boivin, Guy; Hamelin, Marie-Ève; Abed, Yacine // Clinical Infectious Diseases;4/1/2004, Vol. 38 Issue 7, p983 

    The human metapneumovirus (hMPV) is a newly described member of the Paramyxoviridae family belonging to the Me-tapneumovirus genus. Since its initial description in 2001, hemp has been reported in most parts of the world and isolated from the respiratory tract of subjects from all age groups....

  • Evaluation of Type-Specific Real-Time PCR Assays Using the LightCycler and J.B.A.I.D.S. for Detection of Adenoviruses in Species HAdV-C. Jones, Morris S.; Hudson, Nolan Ryan; Gibbins, Carl; Fischer, Stephen L. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Sporadically, HAdVs from species HAdV-C are detected in acute respiratory disease outbreaks. To rapidly type these viruses, we designed real-time PCR assays that detect and discriminate between adenovirus types HAdV-C1, -C2, -C5, and -C6. Sixteen clinical isolates from the California Department...

  • Respiratory Syncytial Virus Epidemiology in a Birth Cohort from Kilifi District, Kenya: Infection during the First Year of Life. Nokes, D. James; Okiro, Emelda A.; Ngama, Mwanajuma; White, Lisa J.; Ochola, Rachel; Scott, Paul D.; Cane, Patricia A.; Medley, Graham F. // Journal of Infectious Diseases;11/15/2004, Vol. 190 Issue 10, p1828 

    We report estimates of incidence of respiratory syncytial virus (RSV) infection during the first year of life for a birth cohort from rural, coastal Kenya. A total of 338 recruits born between 21 January 2002 and 30 May 2002 were monitored for symptoms of respiratory infection by home visits and...

  • Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients. Molinos-Quintana, A; Pérez-de Soto, C; Gómez-Rosa, M; Pérez-Simón, J A; Pérez-Hurtado, J M // Bone Marrow Transplantation;Feb2013, Vol. 48 Issue 2, p265 

    Respiratory syncytial virus (RSV) is a potential cause of serious morbidity and even mortality among children undergoing hematopoietic SCT (HSCT). Contrary to the available information regarding the aerosolized formulation of ribavirin, there is a paucity of published studies using i.v....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics